Lawmakers Urge FDA To Rethink Drug Labeling

Law360, New York (January 24, 2008, 12:00 AM EST) -- A group of lawmakers has asked the U.S. Food and Drug Administration to reconsider a proposed rule regarding drug labeling, saying it was designed to shield pharmaceutical and device companies from liability for injuries sustained by American consumers as a result of unsafe products.

Eight congressional Democrats led by Rep. Henry A. Waxman, D-Calif., and Sen. Edward M. Kennedy, D-Mass., said in a letter sent Wednesday to FDA Commissioner Andrew von Eschenbach that they are concerned that the proposal is intended to protect companies from being...
To view the full article, register now.